Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [6505]

Poliovirus therapy for recurrent glioblastoma has three year survival rate of 21 percent

Poliovirus therapy for recurrent glioblastoma has three year survival rate of 21 percent

New regulatory axis revealed for the cancer relevant matrix metalloprotease MMP14

New regulatory axis revealed for the cancer relevant matrix metalloprotease MMP14

Lethal prostate cancer treatment may benefit from combination immunotherapy

Lethal prostate cancer treatment may benefit from combination immunotherapy

Immune profile for successful cancer immunotherapy discovered

T-cell leukaemia: Cancer cells take advantage of 'survival protein'

T-cell leukaemia: Cancer cells take advantage of 'survival protein'

An emerging drug discovery approach to combat cancer

An emerging drug discovery approach to combat cancer

Research team discovers drug compound that stops cancer cells from spreading

Research team discovers drug compound that stops cancer cells from spreading

Transport of lipid-conjugated floxuridine by natural serum albumin for delivery to cancer cells

Transport of lipid-conjugated floxuridine by natural serum albumin for delivery to cancer cells

First major study comparing robotic to open surgery published

First major study comparing robotic to open surgery published

Discovery of a new vehicle peptide opens drug delivery routes

Discovery of a new vehicle peptide opens drug delivery routes

More from ecancer